Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
Dr Neil Mehta underwent medical training at the University of California, San Francisco (UCSF). He was an Intern then a Resident at the Hospital of the University of Pennsylvania before becoming a Fellow in Gastroenterology and Transplant Hepatology at UCSF. He is Associate Professor in Medicine at UCSF and has held this position since 2013. He is specifically interested in issues related to the diagnosis and management of patients with hepatocellular carcinoma (HCC) particularly with regards to outcomes in liver transplantation.
Fujifilm Wako
Unmet needs, therapy management, and real-world experience
Make decisions for a young patient during his cancer journey
Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO
Rechallenge vs switching